A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma

Table 1

Information of the six-lncRNA signature and the nine-mRNA signature.

Type	ID	Locus	Coefficient	HR	95% CI	Value	Cutoff
lncRNA	FAM138B	cg08267300	1.3497	4.436	1.388-6.461		0.6
	HCG11	cg27490387	0.2787	2.181	1.158-4.108		0.10
	KIAA0087	cg25962015	-2.9759	0.043	0.003-0.532		0.72
	MIAT	cg23345500	1.2621	1.408	1.064-3.084		0.04
	PSORS1C3	cg26504835	-1.6876	0.047	0.006-0.350		0.32
	SNHG11	cg27314048	-1.1996	0.111	0.013-0.988		0.85
mRNA	DMRTA2	cg27265170	0.4475	3.839	1.078-4.366		0.23
	DRGX	cg17494438	-1.1456	0.038	0.020-0.718		0.47
	FAM167A	cg02771117	-0.2809	8.842	3.902-10.04		0.41
	FGGY	cg27571329	1.5940	4.524	3.678-5.565		0.69
	FOXI2	cg26115633	0.0342	2.546	1.086-5.971		0.55
	KRTAP2-1	cg24624629	0.1612	1.385	1.195-5.194		0.35
	TCTEX1D1	cg25339566	0.5241	2.711	1.670-4.396		0.10
	TTBK1	cg27363327	0.4388	0.152	0.084-0.275		0.12
	UBE2QL1	cg26692294	0.5770	0.063	0.012-0.342		0.37

HR: hazard ratio; CI: confidence interval.